CIK 0001159036 · Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880488686
- Phone
- (858) 794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,884,955
- in 5 filings, $19.9M under 10b5-1 plans
Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-12 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Grant or award · Performance Stock Units | +20,342 | 20,342 | ||
| 2025-02-12 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Grant or award · Performance Stock Units | +6,050 | 17,409 | ||
| 2025-02-12 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Grant or award · Performance Stock Units | +4,698 | 7,365 | ||
| 2025-02-12 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Grant or award · Performance Stock Unit | +7,269 | 7,269 | ||
| 2025-02-12 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Grant or award · Performance Stock Units | +30,050 | 30,050 | ||
| 2025-02-12 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Grant or award · Performance Stock Units | +6,050 | 17,409 | ||
| 2025-02-12 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Grant or award · Performance Stock Units | +5,221 | 8,184 | ||
| 2025-02-12 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Grant or award · Performance Stock Unit | +6,935 | 6,935 | ||
| 2025-02-12 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Grant or award · Performance Stock Units | +28,662 | 28,662 | ||
| 2025-02-12 | Torley Helen PRESIDENT AND CEO | Grant or award · Performance Stock Units | +24,957 | 71,810 | ||
| 2025-02-12 | Torley Helen PRESIDENT AND CEO | Grant or award · Performance Stock Units | +20,008 | 31,364 | ||
| 2025-02-12 | Torley Helen PRESIDENT AND CEO | Grant or award · Performance Stock Unit | +23,260 | 23,260 | ||
| 2025-02-12 | Torley Helen PRESIDENT AND CEO | Grant or award · Performance Stock Units | +96,155 | 96,155 | ||
| 2025-02-03 | Henderson Jeffrey William Director | Sale 10b5-1 | −1,100 | $55.94 | $62K | 42,511 |
| 2025-02-03 | Henderson Jeffrey William Director | Sale 10b5-1 | −3,900 | $56.41 | $220K | 38,611 |
| 2025-01-06 | Henderson Jeffrey William Director | Sale 10b5-1 | −10,000 | $50.01 | $500K | 43,611 |
| 2025-01-03 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Option exercise | +7,611 | 19,291 | ||
| 2025-01-03 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Shares withheld for taxes | −4,289 | $47.74 | $205K | 15,002 |
| 2025-01-03 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Option exercise · Restricted Stock Units | −7,611 | 7,611 | ||
| 2024-11-29 | MATSUI CONNIE Director | Gift | −10,470 | 183,035 |
Page 23 of 26 · 513 trades